CoLucid Pharmaceuticals, Inc.
CoLucid Pharmaceuticals, Inc. (CLCD) is a publicly traded company in the Unknown sector. Across all available filings, 17 corporate insiders have executed 120 transactions totaling $27.4M, demonstrating a bullish sentiment with $18.7M in net insider flow. The most recent transaction on Mar 1, 2017 involved a transaction of 2,708 shares valued at $125.9K.
CLCD Insider Activity Summary
Who Is Buying CLCD Stock?
No significant insider buying has been recorded for CLCD in the recent period.
Who Is Selling CLCD Stock?
No significant insider selling has been recorded for CLCD in the recent period.
Is CoLucid Pharmaceuticals, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CLCD is bullish with an Insider Alignment Score of 84/100 and a net flow of $18.7M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CLCD Frequently Asked Questions
Understanding CLCD Insider Activity
Insider trading at CoLucid Pharmaceuticals, Inc. (CLCD) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 17 insiders are actively trading CLCD stock, having executed 120 transactions in the past 90 days. The most active insider is Eli &. Co Lilly (Executive), who has made 1 transactions totaling $896.8M.
Related Tools
Track CoLucid Pharmaceuticals, Inc. Insider Activity
Get notified when executives and directors at CLCD file new Form 4 transactions